Affimed
(NASDAQ:AFMD)
$2.14
0.15[7.54%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$2.14
After Hours: 4:04PM EDT
Day Range1.99 - 2.1552 Wk Range1.4 - 7.02Open / Close2.01 / 2.14Float / Outstanding144.5M / 149.3M
Vol / Avg.2.4M / 1.6MMkt Cap319.6MP/E-50d Avg. Price1.92
Div / Yield-Payout Ratio-Total Float144.5MEPS-0.11

Affimed Stock (NASDAQ:AFMD), Quotes and News Summary

Affimed Stock (NASDAQ: AFMD) stock price, news, charts, stock research, profile.

Loading...
Day Range1.99 - 2.1552 Wk Range1.4 - 7.02Open / Close2.01 / 2.14Float / Outstanding144.5M / 149.3M
Vol / Avg.2.4M / 1.6MMkt Cap319.6MP/E-50d Avg. Price1.92
Div / Yield-Payout Ratio-Total Float144.5MEPS-0.11
Globe Newswire - Sep 1, 2022, 6:30AM
Globe Newswire - Jun 30, 2022, 4:00PM
Globe Newswire - Feb 8, 2022, 6:30AM
Seeking Alpha - Nov 15, 2022, 6:44PM
InvestorsObserver - Nov 15, 2022, 10:29AM
TipRanks - Nov 7, 2022, 3:55PM
InvestorsObserver - Nov 4, 2022, 6:49AM
InvestorsObserver - Nov 3, 2022, 2:13PM
InvestorsObserver - Sep 21, 2022, 1:02PM
TipRanks - Aug 12, 2022, 6:05AM
InvestorsObserver - Aug 11, 2022, 2:37PM
InvestorPlace - Jul 25, 2022, 10:43AM
InvestorPlace - Jul 18, 2022, 11:44AM
Seeking Alpha - Jun 29, 2022, 11:02AM
InvestorsObserver - Jun 2, 2022, 1:01PM
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.180-0.110 0.0700
REV7.580M15.009M7.429M
Q2 2022Est.ActualSurprise
EPS-0.170-0.140 0.0300
REV8.670M7.781M-889.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Affimed (AFMD) stock?

A

You can purchase shares of Affimed (NASDAQ: AFMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Affimed's (AFMD) competitors?

A

There are no as such competitors for Affimed.

Q

What is the target price for Affimed (AFMD) stock?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Stifel on Monday, October 10, 2022. The analyst firm set a price target for 2.00 expecting AFMD to fall to within 12 months (a possible -6.54% downside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Affimed (AFMD)?

A

The stock price for Affimed (NASDAQ: AFMD) is $2.14 last updated November 30, 2022, 9:00 PM UTC.

Q

Does Affimed (AFMD) pay a dividend?

A

There are no upcoming dividends for Affimed.

Q

When is Affimed (NASDAQ:AFMD) reporting earnings?

A

Affimed’s Q3 earnings are confirmed for Tuesday, November 15, 2022.

Q

Is Affimed (AFMD) going to split?

A

There is no upcoming split for Affimed.

Q

What sector and industry does Affimed (AFMD) operate in?

A

Affimed is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.